`Sent:
`To:
`Cc:
`Subject:
`
`Rea, Teresa <TRea@crowell.com>
`Thursday, July 28, 2016 11:03 AM
`Munoz, Ruben; William Hare (bill@miplaw.com); materassi@miplaw.com; Lentz, Shannon
`JANS-ZYTIGA
`RE: IPR2016-00286 and IPR2016-01317
`
`Mr. Munoz,
`
`
`This will confirm that if Janssen does not oppose Argentum’s joinder to IPR2016-00286, Argentum agrees to withdraw the
`declaration of Dr. Devalingham and rely on the declaration of Dr. Scott Serels.
`
`
`Thank you.
`
`
`Terry
`
`
`Teresa Stanek Rea
`TRea@crowell.com
`Direct: 1.202.624.2620 | Fax: 1.202.628.5116
`
`Crowell & Moring LLP | www.crowell.com
`1001 Pennsylvania Avenue NW
`Washington, DC 20004
`
`
`From: Munoz, Ruben [mailto:rmunoz@AKINGUMP.com]
`Sent: Wednesday, July 27, 2016 3:43 PM
`To: William Hare (bill@miplaw.com); materassi@miplaw.com; Rea, Teresa; Lentz, Shannon
`Cc: JANS-ZYTIGA
`Subject: IPR2016-00286 and IPR2016-01317
`
`
`
`Dear Counsel for Amerigen and Argentum:
`
`Please confirm that, pursuant to Argentum’s motion for joinder with respect to the above-captioned proceedings, Amerigen
`agrees to allow Argentum to rely on its expert, Dr. Scott Serels. And that, as a result, Argentum will withdraw the declaration of
`Dr. Devalingam Mahalingham and will rely solely on the declaration and testimony of Dr. Serels in the joined proceeding.
`
`Best regards,
`
`Ruben Munoz
`Counsel for Patent Owner Janssen Oncology, Inc.
`
`Ruben H. Muñoz
`AKIN GUMP STRAUSS HAUER & FELD L L P
`Two Commerce Square | 2001 Market Street | Suite 4100 | Philadelphia, PA 19103-7013 | USA | Direct: +1 215.965.1263 | Internal: 21263
`Fax: +1 215.965.1210 | Mobile: +1 215.807.9595 | rmunoz@akingump.com | akingump.com | Bio
`
`
`1
`
`JANSSEN EXHIBIT 2002
`Argentum v. Janssen IPR2016-01317
`
`
`
`
`The information contained in this e-mail message is intended only for the personal and confidential use of the
`recipient(s) named above. If you have received this communication in error, please notify us immediately by e-mail,
`and delete the original message.
`
`2